Mount Sinai Launches AI-Powered Center for Small Molecule Drug Discovery

2 Sources

The Icahn School of Medicine at Mount Sinai has established the AI Small Molecule Drug Discovery Center, integrating artificial intelligence with traditional drug discovery methods to accelerate the development of new therapeutics.

News article

Mount Sinai Pioneers AI-Driven Drug Discovery

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, marking a significant leap in the integration of artificial intelligence (AI) with traditional drug discovery methods. This innovative center aims to revolutionize the identification and design of new small-molecule therapeutics, promising unprecedented speed and precision in drug development 12.

Accelerating Drug Discovery with AI

Unlike conventional drug discovery processes that can span years and cost billions, the AI-driven approach at Mount Sinai enables researchers to rapidly explore vast chemical landscapes. This includes natural products, significantly expediting the identification of promising drug candidates. By leveraging Mount Sinai's expertise in machine learning, chemical biology, and biomedical data science, the center aims to bring innovative treatments to patients faster, particularly for diseases with urgent unmet needs such as cancer, metabolic disorders, and neurodegenerative diseases 12.

Core Focus Areas and AI Integration

The AI Small Molecule Drug Discovery Center will concentrate on three primary areas:

  1. Designing novel drug-like molecules using generative AI
  2. Optimizing existing compounds to enhance efficacy and safety
  3. Predicting drug-target interactions for repurposing known drugs or natural products

Experts at the center plan to revolutionize drug discovery by transforming traditional rational drug design approaches with AI-driven predictions. By training AI models on extensive datasets of molecular structures and biological activity, researchers can anticipate the properties of new compounds before synthesis, potentially saving years of experimental work 12.

Collaborative Efforts and Future Impact

The center will foster collaborations with leading pharmaceutical companies, biotech firms, and academic institutions to drive drug development forward. It will also provide hands-on training for the next generation of scientists through seminars, internship programs, and AI-driven drug discovery hackathons 12.

Dr. Avner Schlessinger, who will lead the center, emphasizes the potential of integrating AI with cutting-edge chemistry and biology to accelerate drug discovery and develop new treatments for complex diseases 12.

Mount Sinai's AI Initiatives

This new center builds upon Mount Sinai's recent AI initiatives, including the launch of a new AI building and the Center for Artificial Intelligence in Children's Health. Dr. Alexander Charney highlights how AI is reshaping the understanding and targeting of diseases at a molecular level, enabling the design of precision therapeutics tailored to the underlying biology of complex disorders 12.

Scientific Advisory Board and Future Prospects

The center is guided by a distinguished Scientific Advisory Board, comprising experts in drug discovery and machine learning. Over the next two years, Mount Sinai expects to make significant breakthroughs in AI-driven drug design, further solidifying its position as a leader in biomedical innovation 12.

As Dr. Schlessinger notes, "We're at the dawn of a new era in drug discovery. By combining AI, computational chemistry, and biomedical research, we're not just making drug discovery faster -- we're making it smarter, more efficient, and more tailored to the biological complexity of human disease" 2.

Explore today's top stories

Databricks Secures $1 Billion Funding at $100 Billion Valuation, Targets AI Database Market

Databricks raises $1 billion in a new funding round, valuing the company at over $100 billion. The data analytics firm plans to invest in AI database technology and an AI agent platform, positioning itself for growth in the evolving AI market.

TechCrunch logoReuters logoCNBC logo

11 Sources

Business

14 hrs ago

Databricks Secures $1 Billion Funding at $100 Billion

SoftBank's $2 Billion Investment in Intel: A Strategic Move in the AI Chip Race

SoftBank makes a significant $2 billion investment in Intel, boosting the chipmaker's efforts to regain its competitive edge in the AI semiconductor market.

TechCrunch logoTom's Hardware logoReuters logo

22 Sources

Business

22 hrs ago

SoftBank's $2 Billion Investment in Intel: A Strategic Move

OpenAI Launches Affordable ChatGPT Go Plan in India, Eyeing Global Expansion

OpenAI introduces ChatGPT Go, a new subscription plan priced at ₹399 ($4.60) per month exclusively for Indian users, offering enhanced features and affordability to capture a larger market share.

TechCrunch logoBloomberg Business logoReuters logo

15 Sources

Technology

22 hrs ago

OpenAI Launches Affordable ChatGPT Go Plan in India, Eyeing

Microsoft Integrates AI-Powered 'COPILOT' Function into Excel Cells

Microsoft introduces a new AI-powered 'COPILOT' function in Excel, allowing users to perform complex data analysis and content generation using natural language prompts within spreadsheet cells.

The Verge logoThe Register logoGeekWire logo

8 Sources

Technology

14 hrs ago

Microsoft Integrates AI-Powered 'COPILOT' Function into

Adobe Revolutionizes PDF with AI-Powered Acrobat Studio

Adobe launches Acrobat Studio, integrating AI assistants and PDF Spaces to transform document management and collaboration, marking a significant evolution in PDF technology.

Wired logoThe Verge logoXDA-Developers logo

10 Sources

Technology

14 hrs ago

Adobe Revolutionizes PDF with AI-Powered Acrobat Studio
TheOutpost.ai

Your Daily Dose of Curated AI News

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.

© 2025 Triveous Technologies Private Limited
Instagram logo
LinkedIn logo